Radiance
Register
Register
Register

RequestUpdated on 26 June 2025

Developing novel immune modulators for improved outcomes in cancer therapy

Marc Creus

CEO at abbmira therapeutics AG

Basel, Switzerland

About

Abbmira is a Swiss biotech startup open to collaboration with academics, clinicians and companies in the field of preclinical R&D in drug-development, in particular in the area of immuno-oncology.

Organisation

abbmira therapeutics AG

Company (SME, Spin-off, Start-up)

Basel, Switzerland

Similar opportunities